Skip to Content
More detailed lists of publications and related activities can be seen at ResearchGate: http://www.researchgate.net/profile/Jess_Fiedorowicz/ Below is a sampling of some articles produced by the Fiedorowicz lab (bold indicates student in laboratory): Fiedorowicz JG, Solomon DA, Leon AC, Endicott J, Li C, Rice JP, and Coryell WH. Manic/hypomanic symptom burden predicts cardiovascular mortality with bipolar disorder in the Collaborative Depression Study, Psychosomatic Medicine 2009, 71(6): 598-606. Fiedorowicz JG, Palagummi NM, Behrendtsen O, Coryell WH, Cholesterol and affective morbidity, Psychiatry Research 2010, 175(1-2): 78-81. Fiedorowicz JG and Haynes WG. Cholesterol, mood, and vascular health: Understanding the relationship. Current Psychiatry, 2010: 9(7): 17-22. Weiner M, Warren L, Fiedorowicz JG, Cardiovascular morbidity and mortality in bipolar disorder, Annals of Clinical Psychiatry 2011: 23(1): 40-47. Fiedorowicz JG, Endicott J, Leon AC, Solomon DA, Coryell W. Subthreshold hypomanic symptoms in conversion from unipolar major depression to bipolar disorder, American Journal of Psychiatry 2011; 168(1): 40-48. Fiedorowicz JG, He J, Merikangas KR. The association between mood and anxiety disorders with vascular disease and risk factors in a nationally-representative sample, Journal of Psychosomatic Research 2011; 70(2): 145-154. Prabhakar M, Haynes WG, Coryell WH, Chrischilles EA, Miller DD, Arndt S, Ellingrod VL, Warren L, and Fiedorowicz JG. Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disorders. Pharmacotherapy, 2011; 21(8): 806-812. Fiedorowicz JG, Coryell WH, Akhter A, Ellingrod VL. Cryptochrome 2 variants, chronicity, and seasonality of mood disorders, Psychiatric Genetics, 2012; 22(6): 305-306. Fiedorowicz JG, Miller DD, Bishop JR, Calarge CA, Ellingrod VL, and Haynes WG. Systematic review and meta-analysis of pharmacological interventions for weight gain from antipsychotics and mood stabilizers, Current Psychiatry Reviews, 2012, 8(1): 25-36. Fiedorowicz JG, Coryell WH, Rice JP, Warren LL, and Haynes WG. Vasculopathy related to manic/hypomanic symptom burden and first generation antipsychotics in a sub-sample from the Collaborative Depression Study (CDS), Psychotherapy and Psychosomatics, 2012, 81: 235-243. Murray DP, Metz NS, Haynes WG, and Fiedorowicz JG. Vascular function is not impaired early in the course of bipolar disorder, Journal of Psychosomatic Research, 2012, 72(3): 195-198. Fiedorowicz JG#, Endicott J, Solomon DA, Keller MB, and Coryell WH. Course of illness following prospectively observed mania or hypomania, Bipolar Disorders, 2012; 14(6): 664-671. Sodhi SK, Linder J, Chenard C, Miller DD, Haynes WG, Fiedorowicz JG#. Evidence for accelerated vascular aging in bipolar disorder, Journal of Psychosomatic Research, 2012, 73: 175-179. Akhter A, Fiedorowicz JG, Zhang T, Potash JB, Cavanaugh J, Solomon DA, Coryell WH. Seasonal variation of manic and depressive symptoms in bipolar disorder, Bipolar Disorders, In Press.
Persons JE, Robinson JG, Ammann EM, Coryell WH, Espeland MA, Harris WS, Manson JE, Fiedorowicz JG. Omega-3 fatty acid biomarkers and depressive symptoms, International Journal of Geriatric Psychiatry, In Press. Linder JR, Sodhi SK, Haynes WG, Fiedorowicz JG. Effects of antipsychotic drugs on cardiovascular variability in participants with bipolar disorder, Human Psychopharmacology, In Press. Fiedorowicz JG#, Jancic D, Potash JP, Butcher B, Coryell WH. Vascular mortality in participants of the bipolar genomics study, Psychosomatics, In Press. Bajpai S, Im KB, Dyken ME, Sodhi SK, Fiedorowicz JG. Obstructive sleep apnea and risk for late life depression, Annals of Clinical Psychiatry, In Press.